Viking Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Viking Therapeutics (VKTX) Posts Q2 Loss of $1.07/Share
August 13, 2015 7:52 AM EDTViking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($1.07), $0.94 worse than the analyst estimate of ($0.13).
The decrease in net loss and net loss per share in the three months ended June 30, 2015 was primarily due to the company recording a $21.2 million estimated license fee liability... More
